Mirum Pharmaceuticals's total assets for Q4 2025 were $842.81M, an increase of 7.35% from the previous quarter. MIRM total liabilities were $528.12M for the fiscal quarter, a 7.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.